277 related articles for article (PubMed ID: 14651590)
21. Differential protective impact of peptide vaccine formulae targeting the lung- and liver-stage of challenge Schistosoma mansoni infection in mice.
Tallima H; Tadros MM; El Ridi R
Acta Trop; 2024 Jun; 254():107208. PubMed ID: 38621620
[TBL] [Abstract][Full Text] [Related]
22. Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni.
Ahmad G; Torben W; Zhang W; Wyatt M; Siddiqui AA
Parasite Immunol; 2009 Mar; 31(3):156-61. PubMed ID: 19222788
[TBL] [Abstract][Full Text] [Related]
23. DNA Vaccine Encoding the Chimeric Form of Schistosoma mansoni Sm-TSP2 and Sm29 Confers Partial Protection against Challenge Infection.
Gonçalves de Assis NR; Batistoni de Morais S; Figueiredo BC; Ricci ND; de Almeida LA; da Silva Pinheiro C; Martins Vde P; Oliveira SC
PLoS One; 2015; 10(5):e0125075. PubMed ID: 25942636
[TBL] [Abstract][Full Text] [Related]
24. Protective and anti-pathology effects of Sm fructose-1,6-bisphosphate aldolase-based DNA vaccine against schistosoma mansoni by changing route of injection.
Saber M; Diab T; Hammam O; Karim A; Medhat A; Khela M; El-Dabaa E
Korean J Parasitol; 2013 Apr; 51(2):155-63. PubMed ID: 23710082
[TBL] [Abstract][Full Text] [Related]
25. Schistosoma mansoni Stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection.
Farias LP; Cardoso FC; Miyasato PA; Montoya BO; Tararam CA; Roffato HK; Kawano T; Gazzinelli A; Correa-Oliveira R; Coulson PS; Wilson RA; Oliveira SC; Leite LC
PLoS Negl Trop Dis; 2010 Feb; 4(2):e597. PubMed ID: 20161725
[TBL] [Abstract][Full Text] [Related]
26.
Morais SB; Figueiredo BC; Assis NRG; Homan J; Mambelli FS; Bicalho RM; Souza C; Martins VP; Pinheiro CS; Oliveira SC
Front Immunol; 2018; 9():1762. PubMed ID: 30105029
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of recombinant protein r140, a polypeptide segment of tegumental glycoprotein Sm25, as a defined antigen vaccine against Schistosoma mansoni.
Suri PK; Goldberg M; Madikizela M; Petzke MM; Bungiro RD; Davies SJ; Chakraborty B; Nguyen KB; McCray JW; Knopf PM
Parasite Immunol; 1997 Nov; 19(11):515-29. PubMed ID: 9427998
[TBL] [Abstract][Full Text] [Related]
28. The profile of IgG1 and IgG2a antibody responses in mice exposed to Schistosoma mansoni.
Mountford AP; Fisher A; Wilson RA
Parasite Immunol; 1994 Oct; 16(10):521-7. PubMed ID: 7870462
[TBL] [Abstract][Full Text] [Related]
29. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
El Ridi R; Tallima H
Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
[TBL] [Abstract][Full Text] [Related]
30. A Strong Humoral Immune Response Induced by a Vaccine Formulation Containing rSm29 Adsorbed to Alum Is Associated With Protection Against
Alves CC; Araujo N; Bernardes WPOS; Mendes MM; Oliveira SC; Fonseca CT
Front Immunol; 2018; 9():2488. PubMed ID: 30450095
[TBL] [Abstract][Full Text] [Related]
31.
Zhang W; Ahmad G; Molehin AJ; Torben W; Le L; Kim E; Lazarus S; Siddiqui AJ; Carter D; Siddiqui AA
J Investig Med; 2018 Dec; 66(8):1124-1132. PubMed ID: 29997146
[TBL] [Abstract][Full Text] [Related]
32. Isotype responses to candidate vaccine antigens in protective sera obtained from mice vaccinated with irradiated cercariae of Schistosoma mansoni.
Richter D; Incani RN; Harn DA
Infect Immun; 1993 Jul; 61(7):3003-11. PubMed ID: 8514407
[TBL] [Abstract][Full Text] [Related]
33. Fasciola gigantica and Schistosoma mansoni: vaccine potential of recombinant glutathione S-transferase (rFgGST26) against infections in mice.
Preyavichyapugdee N; Sahaphong S; Riengrojpitak S; Grams R; Viyanant V; Sobhon P
Exp Parasitol; 2008 Jun; 119(2):229-37. PubMed ID: 18329021
[TBL] [Abstract][Full Text] [Related]
34. DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model.
Sin JI; Bagarazzi M; Pachuk C; Weiner DB
DNA Cell Biol; 1999 Oct; 18(10):771-9. PubMed ID: 10541436
[TBL] [Abstract][Full Text] [Related]
35. Schistosoma mansoni: immunoreactivity of human sera with the surface antigen Sm23.
Köster B; Hall MR; Strand M
Exp Parasitol; 1993 Nov; 77(3):282-94. PubMed ID: 8224084
[TBL] [Abstract][Full Text] [Related]
36. Intradermal immunization of rats with plasmid DNA encoding Schistosoma mansoni 28 kDa glutathione S-transferase.
Dupré L; Poulain-Godefroy O; Ban E; Ivanoff N; Mekranfar M; Schacht AM; Capron A; Riveau G
Parasite Immunol; 1997 Nov; 19(11):505-13. PubMed ID: 9427997
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous priming with DNA encoding Sm-p80 and boosting with Sm-p80 protein confers protection against challenge infection with Schistosoma mansoni in mice.
Le L; Zhang W; Karmakar S; Ahmad G; Torben W; Siddiqui AA
Parasitol Res; 2014 Mar; 113(3):1195-200. PubMed ID: 24452916
[TBL] [Abstract][Full Text] [Related]
38. Multi-epitope schistosome vaccine candidates tested for protective immunogenicity in mice.
Yang W; Jackson DC; Zeng Q; McManus DP
Vaccine; 2000 Aug; 19(1):103-13. PubMed ID: 10924792
[TBL] [Abstract][Full Text] [Related]
39. The Schistosoma mansoni cyclophilin A epitope 107-121 induces a protective immune response against schistosomiasis.
de Melo TT; Mendes MM; Alves CC; Carvalho GB; Fernandes VC; Pimenta DLF; de Moraes Mourão M; Gai F; Kalli M; Coelho A; de Azambuja Ribeiro RIM; Falcone FH; Pereira RADS; Fonseca CT
Mol Immunol; 2019 Jul; 111():172-181. PubMed ID: 31063938
[TBL] [Abstract][Full Text] [Related]
40. Sm16, A
Bernardes WPOS; de Araújo JM; Carvalho GB; Alves CC; de Moura Coelho AT; Dutra ITS; Teixeira SSF; de Azambuja Ribeiro RIM; de Moraes Mourão M; da Silva-Pereira RA; Fonseca CT
J Immunol Res; 2019; 2019():6793596. PubMed ID: 31886307
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
